ANDOVER, Mass., Feb. 10, 2016 /PRNewswire/ -- Royal Philips
(NYSE: PHG AEX: PHIA) today announced the Expression MR400, a new
technology that monitors patients undergoing magnetic resonance
imaging (MRIs), has received 510(k) clearance from the U.S. Food
and Drug Administration (FDA). The MR400 provides ICU-comparable,
bedside quality monitoring in the MR suite for all patients,
including those with serious medical conditions or who require
anesthesia.
In the MR suite, strong electromagnetic fields make it
impossible for clinicians to use traditional patient monitors
without causing complications with the monitor or degradation of
the images. The lack of adequate monitoring is particularly
problematic for patients, including children, who require
anesthesia when getting an MRI. Without the ability to reliably
track key vital signs, clinicians may not know a patient is in
distress until it is too late.
"When a patient is under anesthesia, it's incredibly important
to keep a close eye on their condition so that clinicians can
intervene early to prevent any complications. Clinicians often
compare monitoring anesthetized patients in the MR suite to
piloting a plane in the fog with limited instrumentation," said
Carla Kriwet, CEO of Philips Patient Care and Monitoring Solutions.
"The MR400 gives clinicians comparable detail to patient monitors
in the ICU and other wings of the hospital, providing them with
increased confidence on the condition of their patients."
Raising quality of patient monitoring in the MR
Suite
The MR400 is designed not to create image artifacts or
other interference from the electromagnetic fields when used
according to the labeling, ensuring that patients receive the level
of clinical care and monitoring they need. The MR400 monitors the
same vital signs that are tracked in the operating room and in the
intensive care unit, including heart rate, oxygen and carbon
dioxide levels, body and surface temperatures, and blood pressure,
and also includes advanced ECG monitoring. Patients with serious
medical conditions, including critical care patients or patients
undergoing cardiac procedures, can also be monitored with the
MR400, regardless of whether they are under anesthesia.
Similar to traditional patient monitors, the MR400 uses
intelligent alarms to warn clinicians of severe patient changes,
including desaturation, apnea and extreme bradycardia/tachycardia.
Clinicians and staff are able to customize the monitor settings for
each patient to prioritize warning signals to reduce alarm fatigue.
The new monitoring system uses a touchscreen with the same
interface as other Philips' monitors, making it easier for
clinicians to view and respond to patient data.
Connecting data across the healthcare ecosystem
The
MR400 expands Philips commitment to working with healthcare systems
to create innovative connected health solutions. The MR400 uses
wireless technology, connects with the Electronic Healthcare
Record, and shares information with IntelliBridge Enterprise to
seamlessly send and receive patient information across the
hospital, ensuring that all care team members have access to the
same high quality patient information.
The Expression MR400 builds on the Philips line of MR patient
monitoring solutions, which are used in each of the top 10
children's hospitals in the U.S. For more information on Philips
full suite of patient monitoring solutions, visit
www.philips.com/monitoring.
For further information, please contact:
Kathy O'Reilly
Philips Group Communications
Tel: +1 978-659-2638
Mobile: +1 978-221-8919
Email: kathy.oreilly@philips.com
Twitter: @kathyoreilly
Ingrid Mitchell
Philips Patient Care and Monitoring Solutions
Tel: +1 978-482-5949
Mobile: +1 617-599-6624
Email: ingrid.e.mitchell@philips.com
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a diversified health and well-being
company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and
Lighting. Headquartered in the
Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately
104,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new
lighting applications, as well as male shaving and grooming and
oral healthcare. News from Philips is located at
www.philips.com/newscenter.
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-secures-510k-clearance-to-market-new-patient-monitoring-solution-to-bring-bedside-quality-monitoring-to-the-mr-suite-300217551.html
SOURCE Royal Philips